1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Concentration ratios involving Lac, NAA, Cho, and Cr
Concentration Ratio Control Group (n = 10) Neonatal Encephalopathy Infants (n = 17) P Values Normal/Mild Outcome (n = 10) Severe/Fatal Outcome (n = 7) Control Versus Normal/Mild Outcome Control Versus Severe/Fatal Outcome Normal/Mild Outcome Versus Severe/Fatal Outcome [Lac]/[Cr] 0.26 (0.09) 0.33 (0.11) 0.68 (0.28–2.32) .12 .11 .26 [Lac]/[NAA] 0.31 (0.12) 0.39 (0.13) 0.69 (0.38–4.12) .19 .05* .09 [Lac]/[Cho] 0.66 (0.26) 0.83 (0.30) 2.33 (0.73–4.81) .19 .06 .22 [NAA]/[Cr] 0.86 (0.15) 0.81 (0.73–0.94) 0.72 (0.14) .79 .08 .09 [NAA]/[Cho] 2.12 (0.28) 2.14 (0.34) 1.90 (1.35–2.08) .89 .16 .34 [Cho]/[Cr] 0.41 (0.08) 0.42 (0.11) 0.40 (0.33–0.43) .82 .81 .88
Note:—Lac indicates lactate; NAA, N-acetylaspartate; Cho, choline; Cr, creatine.
* Denotes statistically significant differences between the groups. Values are mean (SD) and median (interquartile range) as appropriate.